Bicara Therapeutics Common Stock Insider Trades

BCAX

Track insider trading activity from Bicara Therapeutics Common Stock executives and directors. See which insiders are buying and selling BCAX stock.

Trades Last 12 Months

BCAX Price

All Insider Trades for Bicara Therapeutics Common Stock

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cohlhepp Ryan President, COO & Interim CEO
Holding Value $636k 34,252 shares
Last Trade
Sep 08, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$415k 17,500 shares
$23.71
$18.56
Hyep Ivan Chief Financial Officer
Holding Value $2.41M 129,855 shares
Last Trade
Aug 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$350k 12,500 shares
$27.97
$18.56
Mazumdar Claire Chief Executive Officer
Holding Value $6.91M 372,152 shares
Last Trade
Aug 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$277k 10,000 shares
$27.73
$18.56
Bender Jeremy Director
Holding Value $723k 38,950 shares
Last Trade
Jul 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.05M 38,950 shares
$26.88
$18.56
Holding Value $361k 19,475 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 19,475 shares
$20.56
$18.56
Holding Value $361k 19,475 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 19,475 shares
$20.56
$18.56
Holding Value $361k 19,475 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 19,475 shares
$20.56
$18.56
Simson Jake Director
Holding Value $361k 19,475 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 19,475 shares
$20.56
$18.56
Holding Value $361k 19,475 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 19,475 shares
$20.56
$18.56
Haviland Kate Director
Holding Value $361k 19,475 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 19,475 shares
$20.56
$18.56
Powell Michael Director
Holding Value $361k 19,475 shares
Last Trade
Jun 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 19,475 shares
$20.56
$18.56
Schelman William Chief Medical Officer
Holding Value $1.58M 85,000 shares
Last Trade
May 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.92M 85,000 shares
$22.58
$18.56
Raben David Chief Medical Officer
Holding Value $1.13M 60,786 shares
Last Trade
Apr 27, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$124k 5,500 shares
$22.48
$18.56
Holding Value $85.4M 4,603,418 shares
Last Trade
Feb 26, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.8M 300,000 shares
$16.00
$18.56
Meisner Lara Chief Legal Officer
Holding Value $1.67M 90,000 shares
Last Trade
Feb 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.51M 90,000 shares
$16.76
$18.56
Powell Michael Director
Holding Value $441k 23,746 shares
Last Trade
Jun 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$273k 23,746 shares
$11.48
$18.56
Lonberg Nils Director
Holding Value $441k 23,746 shares
Last Trade
Jun 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$273k 23,746 shares
$11.48
$18.56
Flynn James E 10% owner, other, Possible Members Of 10% Group
Holding Value $16M 862,587 shares
Last Trade
Sep 17, 2024 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$18.56
Biocon Ltd 10% owner
Holding Value $0 0 shares
Last Trade
Sep 16, 2024 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$18.56
Tpg Gp A, Llc other, Former 10% Owner
Holding Value $36.4M 1,960,425 shares
Last Trade
Sep 16, 2024 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
No data
No data
$18.56

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up